SND1 and bladder transitional cell carcinoma: SND1, a transcriptional co-activator overexpressed in tumors (Additional file 3: Fig. S3D; Wilcoxon rank-sum test, FDR < 0.01), is also associated with poor patient prognoses in the TCGA BLCA cohort (Fig. 2J).